Filters
Other countries
Results: 1 to 18 of 18
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
AARS2 Gene Combined oxidative phosphorylation deficiency type 8 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 287 | 218 |
|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 122 | 128 |
|
CCDC50 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Invitae Comprehensive Deafness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 405 | 219 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 362 | 227 |
|
Deafness, Autosomal Dominant 44 (DFNA44) via the CCDC50 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Comprehensive Hearing Loss + mtDNA MNG Laboratories (Medical Neurogenetics, LLC.) United States | 218 | 300 |
|
Deafness, autosomal dominant 44 (sequence analysis of CCDC50 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 40 | 39 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 198 | 157 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 18 of 18
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.